Company Performance - Booking Holdings (BKNG) closed at $4,237.75, reflecting a -1.23% change from the previous day's closing price, underperforming the S&P 500's daily gain of 0.54% [1] - Over the past month, shares of Booking Holdings have appreciated by 5.46%, contrasting with the Retail-Wholesale sector's loss of 4.96% and the S&P 500's loss of 4.71% [1] Earnings Expectations - The upcoming earnings report for Booking Holdings is expected to show an EPS of $29.5, representing an 18.9% increase compared to the same quarter last year [2] - Revenue is anticipated to reach $5.5 billion, indicating a 15.45% increase from the same quarter last year [2] Full Year Projections - For the full year, Zacks Consensus Estimates project earnings of $266.94 per share and revenue of $30 billion, reflecting changes of +17.05% and +11.46% respectively from the previous year [3] - Recent changes to analyst estimates for Booking Holdings are significant as they indicate shifting near-term business trends, with positive revisions suggesting a favorable business outlook [3] Valuation Metrics - Booking Holdings has a Forward P/E ratio of 16.07, which is a premium compared to the industry average Forward P/E of 15.01 [6] - The company has a PEG ratio of 0.98, compared to the Internet - Commerce industry's average PEG ratio of 0.85 [6] Industry Context - The Internet - Commerce industry, part of the Retail-Wholesale sector, holds a Zacks Industry Rank of 162, placing it in the bottom 34% of over 250 industries [7] - The Zacks Industry Rank assesses the strength of industry groups, indicating that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Core Viewpoint - Oscar Health, Inc. is experiencing notable stock performance changes and is preparing for an earnings release that is expected to show significant growth in both earnings per share (EPS) and revenue compared to the previous year [2][3]. Group 1: Stock Performance - Oscar Health, Inc. closed at $12.21, reflecting a +1.5% change from the previous day, outperforming the S&P 500's daily gain of 0.54% [1] - Over the last month, the company's shares have decreased by 2.2%, which is better than the Finance sector's loss of 5.77% and the S&P 500's loss of 4.71% [1]. Group 2: Earnings and Revenue Estimates - The upcoming EPS for Oscar Health, Inc. is projected at $1.21, indicating a 31.52% increase compared to the same quarter last year [2]. - Revenue is expected to reach $4.89 billion, representing a 60.62% increase compared to the year-ago quarter [2]. - For the annual period, earnings are anticipated to be $0.2 per share, with revenue projected at $18.91 billion, reflecting increases of +111.83% and +61.62% respectively from the previous year [3]. Group 3: Analyst Estimates and Rankings - Recent adjustments to analyst estimates for Oscar Health, Inc. suggest positive sentiment regarding the company's business and profitability [3]. - The Zacks Rank system currently rates Oscar Health, Inc. as 3 (Hold), indicating a neutral outlook [5]. Group 4: Valuation Metrics - Oscar Health, Inc. is trading with a Forward P/E ratio of 59.16, significantly higher than the industry average of 9.28, indicating a premium valuation [6]. - The Insurance - Multi line industry, to which Oscar Health belongs, has a Zacks Industry Rank of 146, placing it in the bottom 41% of over 250 industries [6].

Core Viewpoint - Grab Holdings Limited (GRAB) is experiencing a decline in stock performance, with a recent trading price of $3.73, reflecting a -1.58% change from the previous day and an 8.67% decrease over the last month [1] Financial Performance - The upcoming earnings report for Grab Holdings is anticipated to show an EPS of $0.03, which represents a 200% increase from the same quarter last year, with a projected revenue of $927.37 million, indicating a 19.97% rise year-over-year [2] - For the full year, analysts expect earnings of $0.09 per share and revenue of $4.07 billion, marking increases of +50% and +20.76% respectively from the previous year [3] Analyst Estimates - Recent changes in analyst estimates for Grab Holdings suggest a favorable outlook on the company's business health and profitability, as positive revisions typically correlate with stock price performance [4][5] Valuation Metrics - Grab Holdings is currently trading at a Forward P/E ratio of 42.11, which is a premium compared to the industry average of 18.85, and has a PEG ratio of 0.85, below the industry average PEG ratio of 1.05 [6] Industry Context - The Internet - Software industry, which includes Grab Holdings, ranks in the bottom 36% of all industries according to the Zacks Industry Rank, indicating a relatively weak performance compared to other sectors [7]

Company Performance - Albemarle's stock closed at $181.39, reflecting a +2.45% increase from the previous day, outperforming the S&P 500's gain of 0.54% [1] - The stock has decreased by 5.23% over the past month, contributing to a 14.52% loss in the Basic Materials sector, which is greater than the S&P 500's loss of 4.71% [1] Upcoming Financial Results - The upcoming earnings per share (EPS) for Albemarle is projected at $0.78, indicating a significant increase of 533.33% from the same quarter last year [2] - Revenue is expected to reach $1.28 billion, representing an 18.91% increase compared to the previous year [2] Annual Estimates - For the annual period, earnings are anticipated to be $8.15 per share, reflecting a remarkable increase of 1131.65% from last year, with revenue projected at $5.58 billion, an increase of 8.48% [3] - Recent changes in analyst estimates suggest a favorable outlook on the company's business health and profitability [3] Analyst Ratings - The Zacks Rank system currently rates Albemarle as 1 (Strong Buy), which has historically outperformed with an average annual return of +25% since 1988 [5] - Over the last 30 days, the Zacks Consensus EPS estimate has increased by 21.51% [5] Valuation Metrics - Albemarle is currently trading at a Forward P/E ratio of 21.73, which is higher than the industry average of 18.27, indicating a premium valuation [6] - The company has a PEG ratio of 1.36, compared to the industry average PEG ratio of 1.51 [6] Industry Context - The Chemical - Diversified industry, which includes Albemarle, has a Zacks Industry Rank of 200, placing it in the bottom 19% of over 250 industries [7] - The Zacks Industry Rank assesses the strength of industry groups based on the average Zacks Rank of individual stocks, with top-rated industries outperforming the bottom half by a factor of 2 to 1 [7]

Company Performance - Builders FirstSource (BLDR) shares increased by 1.75% to $85.41, outperforming the S&P 500's gain of 0.54% on the same day [1] - Over the past month, BLDR shares have depreciated by 23.47%, significantly underperforming the Retail-Wholesale sector's loss of 4.96% and the S&P 500's loss of 4.71% [1] Upcoming Financial Results - The company is expected to report an EPS of $0.45, reflecting a 70.2% decline compared to the same quarter last year [2] - Revenue is anticipated to be $3.17 billion, indicating a 13.31% decrease from the same quarter last year [2] Full-Year Estimates - Zacks Consensus Estimates project earnings of $5.85 per share and revenue of $14.97 billion for the full year, representing year-over-year changes of -15.09% and -1.44%, respectively [3] - Recent revisions to analyst forecasts for Builders FirstSource are crucial as they indicate changing business trends, with positive revisions seen as favorable for the business outlook [3] Valuation Metrics - Builders FirstSource has a Forward P/E ratio of 14.35, which aligns with the industry average [6] - The company has a PEG ratio of 2.03, compared to the Building Products - Retail industry's average PEG ratio of 1.28 [7] Industry Context - The Building Products - Retail industry is part of the Retail-Wholesale sector and currently holds a Zacks Industry Rank of 235, placing it in the bottom 5% of over 250 industries [8] - The Zacks Industry Rank measures the strength of industry groups, indicating that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Company Performance - Comcast's stock closed at $28.74, down 1.64% from the previous trading session, underperforming the S&P 500, which gained 0.54% [1] - The stock has decreased by 7.56% over the past month, compared to a 3.66% loss in the Consumer Discretionary sector and a 4.71% loss in the S&P 500 [1] Upcoming Earnings Report - Comcast is set to release its earnings report on April 23, 2026, with expected earnings of $0.88 per share, reflecting a year-over-year decline of 19.27% [2] - The Zacks Consensus Estimate for revenue is projected at $30.71 billion, indicating a 2.75% increase from the previous year [2] Full Year Estimates - For the full year, earnings are projected at $3.68 per share and revenue at $123.16 billion, representing declines of 14.62% and 0.45% respectively from the prior year [3] - Recent changes to analyst estimates are crucial as they reflect near-term business trends, with positive revisions indicating analysts' confidence in performance [3] Zacks Rank and Valuation - Comcast currently holds a Zacks Rank of 5 (Strong Sell), with the consensus EPS estimate remaining stagnant over the past month [5] - The Forward P/E ratio for Comcast is 7.93, which is higher than the industry average of 6.45, and the PEG ratio stands at 2.28 compared to the Cable Television industry's average PEG ratio of 0.57 [6] Industry Context - The Cable Television industry is part of the Consumer Discretionary sector and has a Zacks Industry Rank of 217, placing it in the bottom 12% of over 250 industries [7] - The Zacks Industry Rank measures the strength of industry groups, with top-rated industries outperforming the bottom half by a factor of 2 to 1 [7]

Company Performance - Amgen's stock closed at $353.93, reflecting a +1.58% increase from the previous day, outperforming the S&P 500's gain of 0.54% [1] - Over the last month, Amgen's shares have decreased by 9%, which is worse than the Medical sector's loss of 8.43% and the S&P 500's loss of 4.71% [1] Earnings Expectations - The upcoming earnings report is expected to show an EPS of $4.74, a decrease of 3.27% compared to the same quarter last year [2] - Revenue is projected to be $8.51 billion, representing a 4.42% increase from the previous year [2] - For the full year, analysts expect earnings of $22.22 per share and revenue of $37.86 billion, indicating changes of +1.74% and +3.02% respectively from last year [3] Analyst Estimates - Recent changes to analyst estimates for Amgen are important as they reflect short-term business trends, with upward revisions indicating positive sentiment towards the company's operations [4] - The Zacks Rank system, which incorporates these estimate changes, currently rates Amgen as 3 (Hold) [6] Valuation Metrics - Amgen is trading at a Forward P/E ratio of 15.68, which is lower than the industry average of 17.97 [7] - The company has a PEG ratio of 3.47, compared to the industry average PEG ratio of 1.46 [8] Industry Context - The Medical - Biomedical and Genetics industry, which includes Amgen, ranks 146 out of over 250 industries, placing it in the bottom 41% [9] - The Zacks Industry Rank indicates that top-rated industries outperform the bottom half by a factor of 2 to 1 [9]

Core Viewpoint - GE Vernova (GEV) is set to report earnings on April 22, 2026, with expectations of significant growth in EPS and revenue compared to the previous year [2] Financial Performance - GEV closed at $923.69, reflecting a +1.57% increase from the previous day, outperforming the S&P 500's gain of 0.54% [1] - Over the past month, GEV shares have increased by 3.37%, while the Oils-Energy sector gained 9.9% and the S&P 500 lost 4.71% [1] - The consensus estimate for GEV's EPS is $1.74, indicating a 91.21% growth year-over-year, with projected quarterly revenue of $9.19 billion, up 14.39% from the same period last year [2] - For the full year, earnings are projected at $14.06 per share, a decrease of 20.52% from the previous year, while revenue is expected to be $44.7 billion, an increase of 17.43% [3] Analyst Estimates and Ratings - Recent changes in analyst estimates for GEV reflect confidence in the company's performance and profit potential [3] - The Zacks Rank system, which evaluates estimate changes, currently ranks GEV at 3 (Hold) [5] - The consensus EPS projection has increased by 0.68% in the past 30 days [5] Valuation Metrics - GEV is trading at a Forward P/E ratio of 64.69, significantly higher than the industry average of 18.93, indicating a premium valuation [6] - The PEG ratio for GEV is 3.59, compared to the industry average of 2.42, suggesting that GEV's valuation is high relative to its expected earnings growth [7] - The Alternative Energy - Other industry, which includes GEV, has a Zacks Industry Rank of 92, placing it in the top 38% of over 250 industries [7][8]

Company Performance - SLB closed at $51.89, reflecting a +2.73% increase from the previous day, outperforming the S&P 500 which gained 0.54% [1] - Over the past month, SLB shares have decreased by 2.58%, while the Business Services sector and S&P 500 fell by 2.15% and 4.71% respectively [1] Upcoming Earnings - SLB's upcoming EPS is projected at $0.6, indicating a 16.67% decline compared to the same quarter last year [2] - Revenue is forecasted to be $8.82 billion, representing a 3.84% increase from the corresponding quarter of the previous year [2] Fiscal Year Estimates - For the entire fiscal year, earnings are projected at $2.85 per share and revenue at $37 billion, reflecting changes of -2.73% and +3.61% respectively from the prior year [3] Analyst Estimates - Recent modifications to analyst estimates for SLB may indicate shifting business dynamics, with positive revisions suggesting optimism about the business outlook [4] - Changes in estimates are believed to correlate with stock price performance, and the Zacks Rank system is designed to leverage this relationship [5] Zacks Rank and Valuation - SLB currently holds a Zacks Rank of 3 (Hold), with a 2.46% decrease in the consensus EPS estimate over the last 30 days [6] - The Forward P/E ratio for SLB is 17.71, which is higher than the industry average of 16.8, while the PEG ratio stands at 3.59 compared to the Technology Services industry average of 1.33 [7] Industry Context - The Technology Services industry, part of the Business Services sector, has a Zacks Industry Rank of 187, placing it in the bottom 24% of over 250 industries [8]

Core Viewpoint - SkyWest (SKYW) has shown a recent stock price increase of 2.65%, but has experienced a significant decline of 14.06% over the past month, underperforming both the Transportation sector and the S&P 500 [1] Financial Performance - The upcoming earnings disclosure is expected to reveal an EPS of $2.19, reflecting a 9.5% decline year-over-year, while revenue is anticipated to be $982.63 million, indicating a 3.6% increase from the same quarter last year [2] - For the entire fiscal year, earnings are projected at $11.42 per share and revenue at $4.33 billion, representing increases of 10.34% and 6.58% respectively compared to the previous year [3] Analyst Estimates - Recent adjustments to analyst estimates for SkyWest are crucial as they reflect short-term business trends, with upward revisions indicating positive sentiment towards the company's operations [4] - The Zacks Rank system, which evaluates these estimate changes, currently assigns SkyWest a rank of 2 (Buy), suggesting a favorable outlook [6] Valuation Metrics - SkyWest has a Forward P/E ratio of 8.04, which is lower than the industry average of 8.57, indicating a potential valuation discount [7] - The company has a PEG ratio of 1.23, compared to the Transportation - Airline industry's average PEG ratio of 0.44, suggesting a higher expected earnings growth rate relative to its peers [8] Industry Context - The Transportation - Airline industry is currently ranked 65 in the Zacks Industry Rank, placing it in the top 27% of over 250 industries, indicating strong performance potential [9]